Project
Curevac RNA Laboratories Enlargement, Tübingen
With a single discovery, CureVac opened the world up to the potential of mRNA to treat diseases and create vaccines. Officially founded in 2000, CureVac is the world’s first company to successfully harness mRNA for medical purposes.
Year: | 2021 |
Project location: | Tübingen, Germany |
Works: |
|
Gallery